Interplay of TLR4 and SARS-CoV-2: Unveiling the Complex Mechanisms of Inflammation and Severity in COVID-19 Infections

Asaba, Clinton Njinju; Ekabe, Cyril Jabea; Ayuk, Humblenoble Stembridge; Gwanyama, Bella Nyemkuna; Bitazar, Razieh et Bukong, Terence Ndonyi ORCID: https://orcid.org/0000-0003-3898-0617 (2024). Interplay of TLR4 and SARS-CoV-2: Unveiling the Complex Mechanisms of Inflammation and Severity in COVID-19 Infections Journal of Inflammation Research , vol. 17 . pp. 5077-5091. DOI: 10.2147/JIR.S474707.

Prévisualisation

PDF - Version publiée Disponible sous licence Creative Commons Attribution. Télécharger (4MB) | Prévisualisation

Résumé

The late 2019 emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, caused profound and unprecedented disruption to the global socio-economic structure, negatively affecting millions of lives worldwide. A typical hallmark of severe COVID-19 is hyper inflammation due to aberrant cytokine release (cytokine storm) by innate immune cells. Recent studies have revealed that SARS-CoV-2, through its spike (S) protein, can activate the body's innate immune cells via Toll-Like Receptors (TLRs), particularly TLR4. In silico studies have demonstrated that the S protein binds with high affinity to TLR4, triggering downstream signaling processes that result in pro-inflammatory cytokine release. Compared to other TLRs, such as TLR2, TLR4 plays a more significant role in initiating and sustaining the inflammatory response associated with severe COVID-19. Furthermore, interactions between the virus and target cells can enhance the cellular expression of TLR4, making cells more susceptible to viral interactions and subsequent inflammation. This increased expression of TLR4 upon viral entry creates a feedback loop, where heightened TLR4 levels lead to amplified inflammatory responses, contributing to the severity of the disease. Additionally, TLR4's potent activation of inflammatory pathways sets it apart from other TLRs, underscoring its pivotal role in the pathogenesis of COVID-19. In this review, we thoroughly explore the multitude of regulatory signaling pathways that SARS-CoV-2 employs to incite inflammation. We specifically focus on the critical impact of TLR4 activation compared to other TLRs, highlighting how TLR4's interactions with the viral S protein can exacerbate the severity of COVID-19. By delving into the mechanisms of TLR4-mediated inflammation, we aim to shed light on potential therapeutic targets that could mitigate the inflammatory damage caused by severe COVID-19. Understanding the unique role of TLR4 in the context of SARS-CoV-2 infection could pave the way for novel treatment strategies that specifically inhibit this receptor's activity, thereby reducing the overall disease burden and improving patient outcomes.

Type de document:	Article
Mots-clés libres:	ACE2 receptors; SARS-CoV-2; cytokine storm; hyperinflammation; innate immunity; toll-like receptor 4
Centre:	Centre INRS-Institut Armand Frappier
Date de dépôt:	04 août 2024 04:23
Dernière modification:	04 août 2024 04:23
URI:	https://espace.inrs.ca/id/eprint/15922

Gestion Actions (Identification requise)

Modifier la notice